NPPA Fixation of Retail Price for Telmisartan Combination Tablet

Apr 08, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA), on April 2026, under the provisions of the Drugs (Prices Control) Order, 2013, has computed the retail price for a combination drug containing:

Telmisartan 40 mg + Chlorthalidone 12.5 mg + Metoprolol Succinate 23.75 mg (ER equivalent to Metoprolol Tartrate 25 mg) based on August 2025 data.

Existing Price (AIM): ₹13.50 per tablet (excluding GST)

Proposed Retail Price: ₹11.99 per tablet (excluding GST)

The formulation is manufactured by Akums Drugs and Pharmaceuticals Ltd and marketed by Primus Remedies Pvt Ltd.

Impact:

The revised pricing results in a price reduction, ensuring affordability and compliance with price control norms under DPCO.

[Notification No.19(5087)/2026/DP/NPPA/Div.I]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT